Here’s the Safest Way to Get Insanely Rich in the 2021 Gold Bull Market
Gold is screaming higher and smart investors are already cashing in on the #1 Gold Pick of 2021. Yet, you haven’t missed the boat. See how this newly-listed US$5 gold stock offers investors historic gains without mining a single ounce of the metal.
Get the details here...
pixel

ANIX Insider Trading (Anixa Biosciences)

Insider Ownership Percentage: 19.80%
Insider Buying (Last 12 Months): $389,775.05
Insider Selling (Last 12 Months): $0.00

Anixa Biosciences Insider Trading History Chart

Anixa Biosciences Share Price & Price History

$4.15
▼ -0.12 (-2.81%)
As of 06/14/2021 01:00 AM ET
Days: 30 | 90 | 365
Could This Be the Biggest Gold Haul in Years?
Mining dream-team confirms multiple high-grade gold discoveries in two ultra-rich mineral belts. Temporarily undiscovered below US$0.25 per share, it’s one of those rare opportunities where the next drill hole could mean 5X or even 10X gains.
Click here for details...
pixel

Anixa Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/23/2021Emily GottschalkDirectorBuy10,000$4.49$44,900.00
4/19/2021Lewis H Titterton JrDirectorBuy5,000$3.99$19,950.00870,326View SEC Filing Icon  
3/25/2021Amit KumarCEOBuy5,000$4.86$24,300.00277,000View SEC Filing Icon  
3/25/2021Arnold M BaskiesDirectorBuy10,000$4.80$48,000.0015,600View SEC Filing Icon  
1/29/2021Amit KumarCEOBuy10,000$3.73$37,300.00272,000View SEC Filing Icon  
9/11/2020Amit KumarCEOBuy28,000$2.11$59,080.00262,000View SEC Filing Icon  
9/11/2020Lewis H Titterton JrDirectorBuy40,000$2.08$83,200.001,020,326View SEC Filing Icon  
6/15/2020Lewis H Titterton JrDirectorBuy31,083$2.35$73,045.05955,826View SEC Filing Icon  
6/12/2020Amit KumarCEOBuy20,000$2.03$40,600.00234,000View SEC Filing Icon  
3/13/2020Lewis H Titterton JrDirectorBuy5,799$2.12$12,293.88924,743View SEC Filing Icon  
1/17/2020Arnold M BaskiesDirectorBuy10,000$3.74$37,400.0021,000View SEC Filing Icon  
1/14/2020Amit KumarCEOBuy20,000$2.99$59,800.00194,000View SEC Filing Icon  
1/14/2020Lewis H Titterton JrDirectorBuy7,400$3.30$24,420.00913,944View SEC Filing Icon  
9/13/2019Amit KumarCEOBuy10,000$4.12$41,200.00
9/13/2019Lewis H Titterton JrDirectorBuy15,000$4.10$61,500.00
4/29/2019John J MonahanDirectorBuy900$4.22$3,798.00View SEC Filing Icon  
4/26/2019Amit KumarCEOBuy4,000$4.21$16,840.00View SEC Filing Icon  
4/26/2019Arnold M BaskiesDirectorBuy10,000$4.28$42,800.00View SEC Filing Icon  
4/24/2019Amit KumarCEOBuy10,000$4.27$42,700.00View SEC Filing Icon  
4/22/2019Christopher J SchaberCEOBuy5,000$0.72$3,600.0042,325View SEC Filing Icon  
4/22/2019Lewis H Titterton JrDirectorBuy50,000$4.09$204,500.00View SEC Filing Icon  
10/25/2018Amit KumarCEOBuy11,000$3.90$42,900.00View SEC Filing Icon  
10/25/2018Lewis H Titterton JrDirectorBuy2,000$4.05$8,100.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Anixa Biosciences (NASDAQ:ANIX)

7.98% of Anixa Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Anixa Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/21/2021Citadel Advisors LLC19,682$92K0.0%+35.8%0.063%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley8,719$41K0.0%-61.3%0.028%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC19,682$92K0.0%+35.8%0.063%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC26,093$0.12M0.0%N/A0.083%Search for SEC Filing on Google Icon
5/14/2021First Manhattan Co.6,500$30K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/14/2021Stifel Financial Corp20,000$94K0.0%N/A0.064%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC9,998$47K0.0%N/A0.032%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC168,958$0.79M0.0%+51.1%0.538%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG587,481$2.75M0.0%-5.0%1.869%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.102,220$0.48M0.0%+8.8%0.325%Search for SEC Filing on Google Icon
4/28/2021Wealth Alliance Advisory Group LLC20,100$94K0.0%N/A0.064%Search for SEC Filing on Google Icon
4/27/2021Dorsey Wright & Associates8,093$38K0.4%N/A0.026%Search for SEC Filing on Google Icon
4/27/2021Concorde Asset Management LLC13,000$61K0.0%N/A0.041%Search for SEC Filing on Google Icon
2/11/2021B. Riley Wealth Management Inc.12,000$37K0.0%N/A0.046%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp49,291$0.15M0.0%-5.2%0.189%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp51,969$0.16M0.0%+32.0%0.199%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.93,942$0.29M0.0%+8.0%0.360%Search for SEC Filing on Google Icon
11/17/2020Jane Street Group LLC18,495$45K0.0%N/A0.078%Search for SEC Filing on Google Icon
11/13/2020Morgan Stanley14,484$35K0.0%-43.1%0.061%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Anixa Biosciences logo
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain viral protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California.
Read More on Anixa Biosciences

Today's Range

Now: $4.15
$3.93
$4.38

50 Day Range

MA: $4.30
$3.46
$4.92

52 Week Range

Now: $4.15
$1.70
$8.09

Volume

144,604 shs

Average Volume

463,348 shs

Market Capitalization

$130.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41

Who are the company insiders with the largest holdings of Anixa Biosciences?

Anixa Biosciences' top insider investors include:
  1. Lewis H Titterton Jr (Director)
  2. Amit Kumar (CEO)
  3. Arnold M Baskies (Director)
  4. Emily Gottschalk (Director)

Who are the major institutional investors of Anixa Biosciences?

Anixa Biosciences' top institutional shareholders include:
  1. UBS Group AG — 1.87%
  2. Geode Capital Management LLC — 0.54%
  3. BlackRock Inc. — 0.33%
  4. Jane Street Group LLC — 0.08%
  5. Wealth Alliance Advisory Group LLC — 0.06%
  6. Stifel Financial Corp — 0.06%

Which major investors are selling Anixa Biosciences stock?

During the last quarter, ANIX stock was sold by these institutional investors:
  1. UBS Group AG
  2. Morgan Stanley

Which major investors are buying Anixa Biosciences stock?

In the previous quarter, ANIX stock was acquired by institutional investors including:
  1. Geode Capital Management LLC
  2. Jane Street Group LLC
  3. Wealth Alliance Advisory Group LLC
  4. Stifel Financial Corp
  5. Concorde Asset Management LLC
  6. Barclays PLC
  7. BlackRock Inc.
  8. Dorsey Wright & Associates
In the last year, these company insiders have bought Anixa Biosciences stock:
  1. Lewis H Titterton Jr (Director)
  2. Amit Kumar (CEO)
  3. Arnold M Baskies (Director)
  4. Emily Gottschalk (Director)
Here’s the Safest Way to Get Insanely Rich in the 2021 Gold Bull Market
Gold is screaming higher and smart investors are already cashing in on the #1 Gold Pick of 2021. Yet, you haven’t missed the boat. See how this newly-listed US$5 gold stock offers investors historic gains without mining a single ounce of the metal.
Get the details here...
pixel